AI drug discovery company

Peptris

Data as of Oct 17, 2026.

Company facts

Founded

2019

ReportedSource for founded (opens in new tab)
Headquarters

India (Bengaluru)

ConfirmedSource for headquarters (opens in new tab)

Latest funding round

Round: Series A
Date: Feb 18, 2026
Amount: INR 70 crore (INR 700M) (approx. $7.7M)
Lead investor: IAN Alpha Fund and Speciale Invest (co-leads)

ConfirmedSource for the latest round (opens in new tab)

Recent news

Oct 12, 2026

Partnership with India Ministry of Science (TDB-DST)

ReportedSource (opens in new tab)
Feb 18, 2026

Series A: INR 70 crore (INR 700M) (approx. $7.7M)

ConfirmedSource (opens in new tab)
Jan 22, 2026

FDA grants Orphan Drug Designation to its AI-discovered candidate PEPR124 (RT001)

ReportedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.